Targeted Therapy in Metastatic Bladder Cancer: Present Status and Future Directions

Targeted Therapy in Metastatic Bladder Cancer: Present Status and Future Directions

The recommended treatment for metastatic urothelial carcinoma (mUC) patients is platinum-based chemotherapy. Although initial response rates are moderate, the vast majority of patients experience a relapse due to chemoresistance and eventually succumb to their disease. Furthermore, platinum-based ch...

Full description

Bibliographic Details
Main Authors:	Mathijs Scholtes, Maryam Akbarzadeh, Ellen Zwarthoff, Joost Boormans, Tokameh Mahmoudi, Tahlita Zuiverloon
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Applied Sciences
Subjects:	muscle-invasive bladder cancer tyrosine kinase receptor RTK targeted therapy personalized medicine
Online Access:	https://www.mdpi.com/2076-3417/10/20/7102

Similar Items

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
by: Mathijs P. Scholtes, et al.
Published: (2021-01-01)

Role of tyrosine kinases in bladder cancer progression: an overview
by: Amir Sadra Zangouei, et al.
Published: (2020-08-01)

Biomarker-Oriented Therapy in Bladder and Renal Cancer
by: Mathijs P. Scholtes, et al.
Published: (2021-03-01)

Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways
by: Eun Hye Lee, et al.
Published: (2022-10-01)

Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities
by: Marina Gorostiola González, et al.
Published: (2024-03-01)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
by: Martina Minoli, et al.
Published: (2020-08-01)

Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
by: Maya Jeitany, et al.
Published: (2018-04-01)

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
by: Won-Sik Shin, et al.
Published: (2023-07-01)

The impact of autophagy during the development and survival of glioblastoma
by: Joanne E. Simpson, et al.
Published: (2020-09-01)

A Survey on 175 Cases of Bladder Cancer in the Patients Who Referred to the Hospitals Affiliated to Babol University of Medical Sciences, Iran (2001-2011)
by: H Shafi, et al.
Published: (2013-03-01)

A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy
by: Florus C. de Jong, et al.
Published: (2024-04-01)

Role of Repeat Transurethral Resection of Bladder Tumours after Primary Resection: A Retrospective Cross-sectional Study
by: Syed Sajjad Nazir, et al.
Published: (2021-02-01)

Editorial: Recent advances in the treatment of upper urinary tract bladder cancers
by: Łukasz Zapała, et al.
Published: (2023-10-01)

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
by: Kallen Schwark, et al.
Published: (2022-08-01)

ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications
by: Flavia Linguanti, et al.
Published: (2023-12-01)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
by: Aleksandra Simiczyjew, et al.
Published: (2018-09-01)

Bladder Preservation with Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for the Treatment of Muscle-invasive Carcinoma of the Bladder: A Single-Center Experience
by: Chinmayee Agrawal, et al.
Published: (2020-07-01)

Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
by: Jorge Esteban-Villarrubia, et al.
Published: (2023-01-01)

Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement
by: Emily Gill, et al.
Published: (2024-01-01)

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?
by: Ryunosuke Nakagawa, et al.
Published: (2022-11-01)

Folding and Intrinsic Disorder of the Receptor Tyrosine Kinase KIT Insert Domain Seen by Conventional Molecular Dynamics Simulations
by: Julie Ledoux, et al.
Published: (2021-07-01)

Does Generic Cyclic Kinase Insert Domain of Receptor Tyrosine Kinase KIT Clone Its Native Homologue?
by: Julie Ledoux, et al.
Published: (2022-10-01)

Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis
by: Shiv Verma, et al.
Published: (2021-11-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

SURVIVAL OF PATIENTS WITH BLADDER CANCER WHO HAD PARTIAL CYSTECTOMY IS BETTER THAN THOSE WHO HAD RADIOTHERAPY
by: Denny Achmad Prayoga, et al.
Published: (2017-03-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
by: Lea Scherschinski, et al.
Published: (2022-01-01)

RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements
by: Iván Plaza-Menacho, et al.
Published: (2016-12-01)

Molecular cystoscopy: Micro-RNAs could be a marker for identifying genotypic changes for transitional cell carcinoma of the urinary bladder
by: Nilay Mitash, et al.
Published: (2016-01-01)

Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
by: Paula Aldaz, et al.
Published: (2021-11-01)

Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
by: Avilez ND, et al.
Published: (2024-04-01)

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response
by: Diego Teyssonneau, et al.
Published: (2017-05-01)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
by: C. A. Chai, et al.
Published: (2021-05-01)

The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
by: Filippo Torrisi, et al.
Published: (2020-10-01)

Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
by: Mohammad Al-Jundi, et al.
Published: (2020-07-01)

Role of intravoxel incoherent motion MRI in diagnosis and assessment of invasiveness of urothelial bladder carcinoma
by: Mohamed Ali Badawy, et al.
Published: (2024-02-01)

Bladder preservation protocols in the management of muscle-invasive bladder cancer: A systematic review
by: Srikanth Pentyala, et al.
Published: (2018-01-01)

Clinical Utility of Bladder Cancer Biomarkers
by: Laura Maria Krabbe, Georgios Gakis, Yair Lotan
Published: (2020-10-01)

Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer
by: Jillian Marie Walker, et al.
Published: (2022-09-01)

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
by: Joep J. de Jong, et al.
Published: (2019-10-01)